Skip to Content

'
Vinod Ravi, M.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Adjunct Faculty, Translational Genomics Research Institute, Phoenix, AZ

Education & Training

Degree-Granting Education

2001 School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, MS, Epidemiology - Clinical Epidemiology
1998 Medical College Trivandrum, University of Kerala, Kerala, India, MD, Medicine and Surgery

Postgraduate Training

7/2004-6/2007 Clinical Fellowship, Medical Oncology, Roswell Park Cancer Institute, Buffalo, NY
7/2002-6/2004 Clinical Residency, Internal Medicine, St. Vincent's Medical Center - Columbia University College of Physicians and Surgeons, Bridgeport, CT
7/2001-6/2002 Clinical Internship, Internal Medicine, St. Vincent's Medical Center - Columbia University College of Physicians and Surgeons, Bridgeport, CT

Board Certifications

11/2007 American Board of Internal Medicine - Medical Oncology
8/2004 American Board of Internal Medicine - General

Experience/Service

Academic Appointments

Assistant Professor, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, 7/2007-6/2008
Visiting Associate Research Scientist, Molecular Medicine, Columbia University College of Physicians and Surgeons, New York City, NY, 7/2001-6/2004

Other Appointments/Responsibilities

Medical Oncology Fellow, Roswell Park Cancer Institute, Buffalo, NY, 7/2004-6/2007

Honors and Awards

2007 2007 Best Basic Science Research, Roswell Park Cancer Institute
2004 2004 Critical Care House Officer Award, St. Vincent's Medical Center
2003-2004 Humanitarian Award, St. Vincent's Medical Center
1999 Gold Medal in Pharmacology, Medical College Trivandrum
1998 Oustanding Academic Achievement Award, Medical College Trivandrum

Selected Publications

Peer-Reviewed Original Research Articles

1. Aslam MI, Dumont SN, Rubin JB, Yang D, Nolden LK, Ludwig JA, Araujo DS, Ravi V, Patel S, Benjamin RS, Trent JC. CXCR4-CXCL 12 Axis: Pivotal Role as a Metastatic Mediator in Small Cell Sarcoma. Molecular Cancer Therapeutics. In Press.
2. Park M, Ravi V, Conley A, Patel S, Trent J, Lev D, Lazar A, Wang W, Benjamin R, Araujo D. The role of chemotherapy in advanced hemangiopericytom and malignant solitary fibrous tumor. Sarcoma. In Press.
3. Raj SD, Zhou X, Bueso-Ramos CE, Ravi V, Patel S, Benjamin RS, Vadhan-Raj S. Prognostic Significance of Elevated D-Dimer for Survival in Patients with Sarcoma. Am J Clin Oncol 35(5):462-7, 10/2012. e-Pub 6/2011. PMID: 21654313.
4. Ravi V, Patel S. Adjuvant chemotherapy for soft tissue sarcomas. Surg Oncol Clin N Am 21(2):243-53, 4/2012. e-Pub 1/23/2012. PMID: 22365517.
5. Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WL, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clin Sarcoma Res 2(2):2, http;//www.clinicalsarcomaresearch.com/content/2/1/2, 2012. e-Pub 1/24/2012. PMCID: PMC3351704.
6. Ravi V, Wang WL, Lewis VO. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis. Curr Opin Oncol 23(4):361-366, 7/2011. PMID: 21577109.
7. Guadagnolo BA, Zagars GK, Araujo D, Ravi V, Shellenberger TD, Sturgis EM. Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp. Head Neck 33(5):661-7, 5/2011. e-Pub 10/19/2010. PMID: 20960566.
8. Park MS, Ravi V, Araujo DM. Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor. Curr Opin Oncol 22(4):351-5, 7/2010. PMID: 20485168.
9. Ravi V, Park M, Wang W, Patel S. Vascular Sarcomas. Current Oncology Reports, 4/2010.
10. Lahat G, Dhuka AR, Lahat S, Smith KD, Pollock RE, Hunt KK, Ravi V, Lazar AJ, Lev D. Outcome of Locally Recurrent and Metastatic Angiosarcoma. Ann Surg Oncol 16(9):2502-9, 9/2009. e-Pub 6/2009. PMID: 19551444.
11. Ravi V, Wong MK. Strategies and Methodologies for Identifying Molecular Targets in Sarcomas and Other Tumors. Current Treatment Options in Oncology 6(6):487-97, 2005, 6/2005.
12. Ravi V, Hyland A, Cummings KM, Mahoney M. Associations Between Cancer Rates and Risk Factors by Region in New York State 1991-1994. Journal of Cancer Education Suppl to Vol 15(3):39, Fall 2000, 7/2000.

Abstracts

1. Chavez AL, Singh P, Aleman A, Anderson J, Jernigan C, Ravi V. Improvement of time to develop treatment plan at a specialized sarcoma center. Journal of Clinical Oncology (Meeting Abstracts) 30(suppl 34) (#127), 12/2012.

Book Chapters

1. Ravi V, Patel S. Medical Management of Chondrosarcoma. In: Bone Sarcoma, part of the MD Anderson Cancer Series. Ed(s) Lin PP, Patel S. Springer: New York. In Press.
2. Ravi V, Patel S. Desmoid Tumors: Systemic Therapy. In: UPTODATE. Ed(s) Basow, DS: Waltham, MA, http://www.uptodate.com, e-Book 2010.

Grant & Contract Support

Title: A Multi-Center single agent Phase II study of the efficacy of nilotinib in patients with relapsed or metastatic pigmented villondular synovitis/tenosynovial giant cell tumor/diffuse-type giant cell tumor.
Funding Source: Dana-Farber Cancer Institute
Role: Co-Investigator
Duration: 1/19/2011 - 1/31/2013
 
Title: Paclitaxel in Combination with Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma
Funding Source: Genentech, Inc.
Role: Co-Investigator
Duration: 11/18/2010 - 12/31/2011

Last updated: 3/13/2013